Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Times Reporter of Africa.
Press releases published on August 27, 2025
Critical One Closes CDN$3 Million Private Placement
GlobeNewswire
·
August 27, 2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Critical One Energy Inc. (formerly Madison Metals Inc.) (“Critical One” or the “Company”) (CSE: CRTL) (OTCQB: MMTLF) (FSE: 4EF0) …
24/7 Market News: LIXTE Showcases LB-100 at First Global Conference on Oncogenic Signaling Activation as Cancer Therapy
GlobeNewswire
·
August 27, 2025
DENVER, Aug. 27, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, highlights the publication of a new manuscript in Trends in Cancer (July 2025, …
Kailera Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
WALTHAM, Mass. and SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity, today announced …
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
GlobeNewswire
·
August 27, 2025
PHILADELPHIA, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune …
Septerna to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that management will participate …
Lancaster Resources Completes Acquisition of Lac Iris Polymetallic Project
GlobeNewswire
·
August 27, 2025
VANCOUVER, British Columbia, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Lancaster Resources Inc. (CSE:LCR) (OTC Pink:LANRF) (FRA:6UF) (“Lancaster”), is pleased to announce that it has acquired a 100% interest in the Lac Iris Polymetallic Project in the James Bay …
Sonoro GOLD Announces increase in Private Placement
GlobeNewswire
·
August 27, 2025
“THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.” VANCOUVER, Canada, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: …
Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
GlobeNewswire
·
August 27, 2025
SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following investor conferences …
Context Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
PHILADELPHIA, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced that the …
BridgeBio to Participate in September Investor Conferences
GlobeNewswire
·
August 27, 2025
PALO ALTO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will host …
Pasinex Announces Q2 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 27, 2025
TORONTO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Pasinex Resources Limited (CSE: PSE) (FSE: PNX) ("Pasinex" or the "Company") today announced financial results for the second quarter ended June 30, 2025. The financial statements, management’s discussion and …
Minovia Therapeutics מודיעה על מענק של 350,000 דולר מקרןCountdown for a Cure לפיתוח סמנים ביולוגיים מבוססי דם של מיטוכונדריה
GlobeNewswire
·
August 27, 2025
חיפה, ישראל, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Minovia Therapeutics Ltd("מינוביה" או "החברה"), חברת ביוטכנולוגיה בשלבים קליניים המפתחת טיפולים חדשניים לטיפול במחלות מיטוכונדריאליות ולמאבק בהידרדרות הקשורה לגיל, מודיעה כי נבחרה לקבל מענק של 350,000 דולר מ- …
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with autoimmune, inflammatory, and …
Invivyd to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that it will present at the following investor conferences: Cantor Global Healthcare Conference 2025 Fireside Chat Date: Wednesday, September 3, 2025 Fireside …
Quell Therapeutics Establishes World-Class Scientific Advisory Board
GlobeNewswire
·
August 27, 2025
London, UK – 27 August, 2025 – Quell Therapeutics Ltd (“Quell”), a pioneer in engineered T-regulatory (Treg) cell therapies for people with immune-mediated diseases, announces the formation of its Scientific Advisory Board (SAB). The SAB comprises globally …
Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that management will participate in webcast fireside chats at the following investor conferences: Wells Fargo Healthcare Conference Date/Time: …
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- August 27, 2025 -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, …
Ocular Therapeutix™ to Participate in September Investor and Scientific Conferences
GlobeNewswire
·
August 27, 2025
BEDFORD, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming investor and …
Mesoblast Financial Results and Corporate Update Webcast
GlobeNewswire
·
August 27, 2025
NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and financial results for the full year …
MEXC Lists Bitlayer (BTR) and Launches Airdrop+ Event with 120,000 BTR and 35,000 USDT Prize Pool
GlobeNewswire
·
August 27, 2025
VICTORIA, Seychelles, Aug. 27, 2025 (GLOBE NEWSWIRE) -- MEXC, a leading global cryptocurrency exchange, officially listed Bitlayer (BTR) at 10:00 UTC today. To celebrate the listing, MEXC has launched an Airdrop+ event featuring a prize pool of 120,000 BTR …